Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective Autotaxin inhibitor, in healthy subjects: A phase I randomized placebo-controlled trial.

Yang, Ling; Shu, Pei; Wu, Nan; Hu, Mengyue; Luo, Zhu

Yang, Ling; Shu, Pei; Wu, Nan; Hu, Mengyue; Luo, Zhu.

Affiliation

Yang L; Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, 610044, China; Clinical Trial Center, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, 610044, China.
Shu P; Clinical Trial Center, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, 610044, China.
Wu N; Haisco Pharmaceutical Group Co., LtPd., Chengdu, China.
Hu M; Haisco Pharmaceutical Group Co., LtPd., Chengdu, China.
Luo Z; Clinical Trial Center, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan, 610044, China. Electronic address: luozhu720@163.com.

Eur J Pharm Sci ; 189: 106552, 2023 Oct 01.

Article de En | MEDLINE | ID: mdl-37532064

Sujet(s)
Mots clés

Autotaxin inhibitor; Idiopathic pulmonary fibrosis; Pharmacodynamics; Pharmacokinetics; Phase i study; Safety

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fibrose pulmonaire idiopathique Type d'étude: Clinical_trials / Prognostic_studies Limites: Humans Langue: En Journal: Eur J Pharm Sci Sujet du journal: FARMACIA / FARMACOLOGIA / QUIMICA Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google